Skip to main content

Ramon Martí Seves

Institutions of which they are part

Head of group
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Ramon Martí Seves

Institutions of which they are part

Head of group
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Desarrollo de una estrategia de terapia génica para la deficiencia combinada de la fosforilación oxidativa tipo 1 debido a mutaciones en GFM1.

IP: Ramon Martí Seves
Collaborators: -
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 150000
Reference: AP176532021
Duration: 07/07/2021 - 06/07/2025

Eficacia preclínica del uso de desoxiribonucleósidos como tratamiento para los síndromes de depleción/deleciones multiples del DNA mitocondrial (MDDS). Ampliación a causas genéticas no exploradas.

IP: Ramon Martí Seves
Collaborators: Mª Jesus Melia Grimal, Javier Francisco Ramón Pasías
Funding agency: Instituto de Salud Carlos III
Funding: 153670
Reference: PI21/00554
Duration: 01/01/2022 - 31/12/2025

Deoxyribonucleosides as a therapy for mitochondrial DNA replication disorders: understanding therapeutic mechanisms and broadening the treatment to mutations in POLG and other related genes.

IP: Ramon Martí Seves
Collaborators: Yolanda Cámara Navarro, Javier Francisco Ramón Pasías
Funding agency: Fundació La Marató de TV3
Funding: 163812.5
Reference: 97/C/2020
Duration: 01/06/2021 - 31/12/2024

Xarxa R+D+I AGAUR - Acuerdo HUB D’INNOVACIÓ PEDIÀTRICA

IP: Ramon Martí Seves
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: AGAUR/XARXES/2018/MARTI
Duration: 09/04/2020 - 31/12/2023

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Isabel Mª Garlito Pérez

Isabel Mª Garlito Pérez

Main researcher
Multidisciplinary Nursing Research Group
Read more
Hug Cuellar Calabria

Hug Cuellar Calabria

Senior researcher
Molecular Imaging and Therapy
Read more
David Hernandez Morales

David Hernandez Morales

Research technician
Stroke research
Read more
Concepción Gomez Gavara

Concepción Gomez Gavara

Main researcher
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.